JB
Congress trade
Sen. John Boozman (R-AR) bought $1K-$15K of Eli Lilly and Company (LLY) stock
John Boozman, U.S. Senator (R-AR), disclosed a purchase of Eli Lilly and Company (LLY) stock worth $1K-$15K in a STOCK Act filing on Sep 12, 2025.
The trade happened on Aug 11, 2025, 32 days before it was made public.
LLY has moved +79.9% since the trade date, from $635.22 to $1142.85 (Oct 2, 2026 close).
- Traded
- Aug 11, 2025
- Disclosed
- Sep 12, 2025
- Filing delay
- 32 days
- Price since
- +79.9%
- Source
- STOCK Act disclosure
Other trades in this disclosure (20)
- BuyRNWGX$15K-$50KSep 12, 2025
- BuyRNWGX$15K-$50KSep 12, 2025
- BuyAGZ$1K-$15KSep 12, 2025
- BuyAMD$1K-$15KSep 12, 2025
- BuyCMBS$1K-$15KSep 12, 2025
- BuyGEM$1K-$15KSep 12, 2025
- BuyIEF$1K-$15KSep 12, 2025
- BuyIEI$1K-$15KSep 12, 2025
- BuyIWM$1K-$15KSep 12, 2025
- BuyJMBS$1K-$15KSep 12, 2025
- BuyLLY$1K-$15KSep 12, 2025
- BuyMBB$1K-$15KSep 12, 2025
- BuyNVDA$1K-$15KSep 12, 2025
- BuyRNWGX$1K-$15KSep 12, 2025
- BuySCHP$1K-$15KSep 12, 2025
- BuySHY$1K-$15KSep 12, 2025
- BuyTLH$1K-$15KSep 12, 2025
- BuyTLT$1K-$15KSep 12, 2025
- BuyVNQI$1K-$15KSep 12, 2025
- BuyWWSYX$1K-$15KSep 12, 2025
More LLY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.